Morgan Stanley raised target for Synopsys stock to USD 574
π Morgan Stanley raised its Synopsys price target to USD 574 on October 20, 2026, maintaining an Overweight rating.
π° Fiscal third-quarter revenue surged 42.4 percent year-over-year to reach USD 2.48 billion.
π Diluted earnings per share climbed to USD 2.84 with net income of USD 545.8 million for the quarter ended July 31, 2026.
π The company authorized a new USD 1.0 billion share-repurchase program covering up to 1.1 percent of outstanding shares.
π Synopsys stock traded at EUR 383.75 on October 26, 2026, slightly below the EUR 386.00 Xetra close.
π’ The company maintains a market capitalization of USD 82.4 billion as of October 23, 2026.
π― The average analyst consensus target is USD 586.95, with high targets reaching USD 700.00.
π» Synopsys operates in the Technology / Software - Infrastructure sector and recently held its 2026 Investor Day.
- Morgan Stanley raised its price target for Synopsys to USD 574, a 14.8 percent increase from the previous target of USD 500, maintaining an Overweight rating.
- Fiscal third-quarter revenue accelerated significantly by 42.4 percent year-over-year to reach USD 2.48 billion, demonstrating strong top-line growth.
- Diluted earnings per share increased to USD 2.84 with net income attributable to common shareholders reaching USD 545.8 million for the quarter ended July 31, 2026.
- The company authorized a new USD 1.0 billion share-repurchase program covering up to 1.1 percent of outstanding shares, signaling confidence in its capital allocation strategy.
- Analyst consensus targets remain elevated with an average of USD 586.95 and a high target of USD 700.00, indicating strong institutional support.